UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 05, 2023
Accession Number:0001104659-23-067103
Submission Type:POS AM
CIK:0001750019
Company Name:TCR2 THERAPEUTICS INC.
File Number:333-252244
TCR2 Therapeutics (NASDAQ:TCRR)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more TCR2 Therapeutics Charts.
TCR2 Therapeutics (NASDAQ:TCRR)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more TCR2 Therapeutics Charts.